📈 CagriReta Protocol

For educational purposes only. Not medical advice. Please see individual protocols for Cagrilintide and Retatrutide before considering this protocol. 

⸻

When you are deep in a contest prep or simply shaving fat for summer vacay - your body thinks you are starving. It fights back in two ways: it slows down your metabolism to save energy, and it turns up your hunger signals to a screaming volume (this is the dreaded "food noise").

Putting Retatrutide and Cagrilintide together creates a perfect tag-team that attacks this problem from two completely different angles:

1. Retatrutide Keeps the Metabolic Furnace Burning

Most standard diet drugs just stop you from eating, but they don't stop your metabolism from crashing. Retatrutide is different because it triggers three separate fat-burning pathways. Crucially, it activates glucagon receptors, which tell your body to keep burning energy and pulling fat from your cells even when your calories are painfully low.

2. Cagrilintide Shuts Down the "Breakthrough Hunger"

Because Retatrutide makes your body burn through energy so fast, it can actually trigger a survival response—meaning some people get hit with intense, out-of-nowhere cravings while taking it alone. This is where Cagrilintide comes in.

Cagrilintide isn't a standard GLP-1 drug; it mimics a hormone called amylin, which tells your brainstem that your stomach is physically full.

The Symbiotic Loop (How They Help Each Other)

Instead of fighting your biology, this combination creates a perfect circle of defense:

  • Retatrutide forces your body to keep burning fat and prevents your metabolism from stalling out.

  • Cagrilintide steps in to completely mute the intense hunger and food noise that burning fat at that speed naturally causes.

The Takeaway: It allows a competitor to stay perfectly on track with an extreme, low-calorie diet without their metabolism crashing, and without having to rely on pure willpower to fight off constant cravings.

⸻

Theoretical titration

================================================================================
TIMELINE          RETATRUTIDE DOSE    CAGRILINTIDE DOSE   PRIMARY RESEARCH FOCUS
================================================================================
Weeks 1–4         2.0 mg / weekly     0.3 mg / weekly     Adaptation Phase
Weeks 5–8         4.0 mg / weekly     0.6 mg / weekly     Metabolic Engagement
Weeks 9–12        6.0 mg / weekly     1.2 mg / weekly     Synergy Realization
Weeks 13–16       9.0 mg / weekly     2.4 mg / weekly     High-Dose Consolidation
Weeks 17+         12.0 mg / weekly    4.5 mg / weekly     Peak Maintenance Ceiling